Oili Kaipiainen-Seppanen
Overview
Explore the profile of Oili Kaipiainen-Seppanen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elfving P, Kononoff A, Huhtakangas J, Kautiainen H, Savolainen E, Arstila L, et al.
Rheumatol Int
. 2023 Jan;
43(4):659-666.
PMID: 36629937
The objective is to evaluate the incidence of seropositive rheumatoid arthritis (RA) over 40-year period in Northern Savo, Finland. Data on new seropositive RA patients according to the American College...
2.
Elfving P, Kautiainen H, Virta L, Kaipiainen-Seppanen O, Puolakka K
Clin Exp Rheumatol
. 2021 Jan;
40(1):39-43.
PMID: 33506756
Objectives: Systemic lupus erythematosus (SLE) patients are considered as a high-risk population for cardiovascular diseases (CVDs). To explore whether their risk is increased already in preclinical episodes of the disease,...
3.
Elfving P, Kariniemi S, Kautiainen H, Virta L, Kaipiainen-Seppanen O, Puolakka K
Rheumatology (Oxford)
. 2021 Jan;
60(9):4238-4244.
PMID: 33404636
Objective: To estimate the risk of mortality in the Finnish incident SLE cohort in a 16-year period compared with the general population. Methods: Adults with new-onset SLE between 1 January...
4.
Kononoff A, Vuolteenaho K, Hamalainen M, Kautiainen H, Elfving P, Savolainen E, et al.
J Clin Rheumatol
. 2020 May;
27(8):e349-e356.
PMID: 32453216
Objective: To investigate metabolic syndrome (MetS), disease activity, and adipokine levels among patients with rheumatoid arthritis (RA), spondyloarthritis (SpA), and undifferentiated arthritis (UA) at the time of diagnosis and after...
5.
Kononoff A, Elfving P, Pussinen P, Horkko S, Kautiainen H, Arstila L, et al.
Ann Med
. 2020 Feb;
52(1-2):32-42.
PMID: 32011179
We investigated lipid concentrations, particle sizes and antibodies binding to periodontal bacteria and and to malondialdehyde-acetaldehyde (MAA) modified low-density lipoprotein in immunoglobulin (Ig) class A, G and M among patients...
6.
Sandstrom T, Rantalaiho V, Yli-Kerttula T, Kautiainen H, Malmi T, Karjalainen A, et al.
J Rheumatol
. 2019 Nov;
47(8):1160-1164.
PMID: 31732558
Objective: To evaluate the development of radiological changes of the cervical spine in patients with rheumatoid arthritis (RA) in the NEO-RACo trial treated with an intensive, remission-targeted combination of conventional...
7.
Rantalaiho V, Sandstrom T, Koski J, Hannonen P, Mottonen T, Kaipiainen-Seppanen O, et al.
Arthritis Care Res (Hoboken)
. 2018 Oct;
71(11):1450-1458.
PMID: 30295425
Objective: The short-term outcomes of remission-targeted treatments of rheumatoid arthritis (RA) are well-established, but the long-term success of such strategies is speculative, as is the role of early add-on biologics....
8.
Elfving P, Puolakka K, Rantalaiho V, Kautiainen H, Virta L, Kaipiainen-Seppanen O
Clin Rheumatol
. 2018 Mar;
37(5):1413-1416.
PMID: 29541950
Objectives of this study were to examine work disability (WD) and its leading causes in incident SLE patients. Data were derived from the Finnish nationwide registries to identify all non-retired,...
9.
Vaananen T, Vuolteenaho K, Kautiainen H, Nieminen R, Mottonen T, Hannonen P, et al.
PLoS One
. 2017 Aug;
12(8):e0183294.
PMID: 28841649
Objective: YKL-40, a chitinase-like glycoprotein associated with inflammation and tissue remodeling, is produced by joint tissues and recognized as a candidate auto-antigen in rheumatoid arthritis (RA). In the present study,...
10.
Elfving P, Puolakka K, Kautiainen H, Virta L, Pohjolainen T, Kaipiainen-Seppanen O
Clin Exp Rheumatol
. 2017 Jan;
35(2):352.
PMID: 28094755
No abstract available.